3B Blackbio DX Ltd.

NSE: 3BBLACKBIO · Healthcare Service Provider · sector

₹1,392.70NSE close 2026-10-26

Key numbers

Market cap₹1,193 cr

Price₹1,392.70

52w high / low₹1,740 / ₹1,085

P/E21.2xSector median 22.9x

P/B3.7xSector median 2.0x

Book value₹378.6

Dividend yield0.29%Sector median 0.55%

ROE18.7%Sector median 5.4%

ROCE22.8%Sector median 6.8%

OPM34.9%Sector median 15.9%

Debt / equity0.01xSector median 0.07x

EV/EBITDA20.5xSector median 17.2x

Interest cover226.8x

Current ratio5.27x

Sales growth 3y+127.8%Sector median +13.5%

Profit growth 3y+200.5%Sector median +26.9%

PEG0.11x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 31 companies in Healthcare Service Provider (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹101 cr vs borrowings ₹3 cr (FY26): cash is higher (net cash).
Operating profit covered interest 226.8x in the last 12 months.
Other income was 49% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹1,392.70 on 2026-10-26: -20.0% from the 52-week high, +28.4% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹2,089.80 · low ₹1,113.50

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	22	22	34	50	35	33
EBITDA	8	12	15	22	8	9
OPM %	35.2%	53.2%	43.5%	43.1%	24.0%	25.4%
Other income	5	4	6	6	10	6
Net profit	8	13	15	22	10	10
EPS (₹)	9.38	14.76	17.55	26.19	11.44	10.48
Revenue YoY					+57.5%	+50.7%
Profit YoY					+13.8%	-24.3%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	16	12	71	96	142	153
EBITDA	-1	-1	35	50	57	53
Net profit	8	2	34	48	59	56
EPS (₹)	10.67	2.88	39.93	55.66	69.94	65.66
Revenue growth		-22.7%	+489.4%	+36.4%	+47.1%	–
Profit growth		-73.0%	+1,483.8%	+39.3%	+23.0%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+127.8%	–	–
Net profit	+200.5%	–	–
EPS	+189.6%	–	–
Share price	–	– (2y)	–

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	268	324
Borrowings	0	3
Cash & equivalents	69	101
Total assets	296	378
Fixed assets	7	28
Investments	156	158
Receivables	37	50
Inventory	9	18
Payables	2	7

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	43	52
Cash from investing	-34	-24
Cash from financing	-3	-1
Capex	1	26
Free cash flow	42	27

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	17.8%	18.1%
ROCE %	23.9%	23.6%
Debtor days	138	129
Inventory days	124	187
Payable days	28	70
Cash conversion cycle (days)	234	246
Working capital days	430	402

Peers in Healthcare Service Provider

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
LALPATHLAB	₹31,100 cr	57.2x	12.4x	23.1%	29.6%	27.9%	+11.1%	0.71%
VIJAYA	₹14,362 cr	76.6x	15.0x	21.4%	30.1%	42.2%	+21.0%	0.14%
METROPOLIS	₹10,989 cr	54.5x	7.3x	14.2%	19.7%	24.2%	+12.8%	0.19%
THYROCARE	₹7,491 cr	42.6x	12.8x	31.1%	39.7%	31.4%	+16.3%	1.99%
NEPHROPLUS	₹6,095 cr	71.6x	5.5x	6.9%	13.4%	22.7%	–	–
SURAKSHA	₹1,628 cr	45.4x	6.7x	15.7%	25.2%	31.4%	–	–
KRSNAA	₹1,617 cr	16.6x	1.6x	10.5%	11.1%	26.8%	+16.6%	0.55%
3BBLACKBIO	₹1,193 cr	21.2x	3.7x	18.7%	22.8%	34.9%	+127.8%	0.29%
HEALTHX	₹857 cr	–	3.2x	-0.5%	–	–	–	–
ONEGLOBAL	₹773 cr	10.5x	5.5x	69.4%	69.9%	19.2%	+201.8%	–

All 31 companies in Healthcare Service Provider →

Business segments (2026-06-30)

Segment	Revenue	Share	EBIT	Margin
Diagnostic Kits	₹32 cr	95.7%	₹13 cr	41.6%
Agrochemicals	₹1 cr	4.3%	₹0 cr	0.0%

Dividends & corporate actions

Ex-date	Action	Detail
2026-09-22	Dividend	Dividend - Rs 5 Per Share

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Healthcare Service Provider
Sub-industry	Healthcare Service Provider
Symbol	3BBLACKBIO
BSE code	532067
ISIN	INE994E01018
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-23 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = NSE close 2026-10-26.